Rachel H Tan (R H Tan)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 6

Top Topics

Sensitive Detection

Replacement Therapy

Amyotrophic Lateral Sclerosis

Top Venues

Neuropathology and applied neurobiology

Journal of neuropathology and experimental neurology

Acta neuropathologica communications

This page only lists publications with an associated author ORCID identifier.

Publications

Matthew C Kiernan, Glenda M Halliday, Dominic B Rowe, Rachel H Tan
The importance of patient-centred drug development for amyotrophic lateral sclerosis. Neuropathology and applied neurobiology 49 (6) (2023)
Matthew C Kiernan, Glenda M Halliday, Dominic B Rowe, Rachel H Tan
The importance of patient-centred drug development for amyotrophic lateral sclerosis. Neuropathology and applied neurobiology 49 (6) (2023)
Monica Pinkerton, Guinevere Lourenco, Maria Torres Pacheco, Glenda M Halliday, Matthew C Kiernan, Rachel H Tan
Survival in sporadic ALS is associated with lower p62 burden in the spinal cord. Journal of neuropathology and experimental neurology (2023)
Rachel H Tan, Heather McCann, Claire E Shepherd, Monica Pinkerton, Srestha Mazumder, Emma M Devenney, Gabrielle L Adler, Dominic B Rowe, Jillian Kril, Glenda M Halliday, Matthew C Kiernan
Heterogeneity of cortical pTDP-43 inclusion morphologies in amyotrophic lateral sclerosis. Acta neuropathologica communications 11 (1) (2023)
Yue Yang, Dominic Rowe, Heather McCann, Claire E Shepherd, Jillian June Kril, Matthew C Kiernan, Glenda M Halliday, Rachel H Tan
Treatment with the copper compound CuATSM has no significant effect on motor neuronal pathology in patients with ALS. Neuropathology and applied neurobiology (2023)
Rachel H Tan, Y Yang, Glenda M Halliday
Multiple neuronal pathologies are common in young patients with pathologically proven Frontotemporal lobar degeneration. Neuropathology and applied neurobiology 44 (5) (2018)